CGL
NGM

Clarius Group LLC’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Clarius Group LLC’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,912
Closed -$42.8K – 502
2024
Q1 		$42.8K Buy
26,912
+306
+1% +$487 ﹤0.01% 479
2023
Q4 		$22.9K Buy
+26,606
New +$22.9K ﹤0.01% 476